Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sirkku Jyrkkio"'
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Marginal zone lymphoma (MZL) is an indolent B-cell malignancy with heterogeneous anatomical and clinical presentation. While MZLs are generally associated with long survival, some patients experience histological transformation to aggressive
Externí odkaz:
https://doaj.org/article/b2a75e332a1c4313962dcc9cc3bae999
Autor:
Marja‐Liisa Huuskonen, Tero Koistinen, Niina Sihvola, Inkeri Parkkari, Sanna Palovaara, Ville Kytö, Jussi Sipilä, Sirkku Jyrkkiö, Eetu Heervä
Publikováno v:
Cancer Medicine, Vol 12, Iss 6, Pp 7406-7413 (2023)
Abstract Background Little controlled evidence exists on road traffic accident (RTA) risk among patients diagnosed with cancer, while clinicians are often requested to comment their ability to drive. The aim of this study was to evaluate RTA risk in
Externí odkaz:
https://doaj.org/article/600faf4c88f9473485cf964194d8fe4d
Autor:
Mikko S. Venäläinen, Eetu Heervä, Outi Hirvonen, Sohrab Saraei, Tomi Suomi, Toni Mikkola, Maarit Bärlund, Sirkku Jyrkkiö, Tarja Laitinen, Laura L. Elo
Publikováno v:
Cancer Medicine, Vol 11, Iss 3, Pp 654-663 (2022)
Abstract Background The existing risk prediction models for chemotherapy‐induced febrile neutropenia (FN) do not necessarily apply to real‐life patients in different healthcare systems and the external validation of these models are often lacking
Externí odkaz:
https://doaj.org/article/a4accec3641e4b499630a58b899048de
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 12, Pp 1-6 (2021)
Abstract Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) is a rare B-cell malignancy associated with excellent survival. However, some patients experience histological transformation into aggressive large B-cell lymphoma. Population-based dat
Externí odkaz:
https://doaj.org/article/7cdbd33b83c44b75b830291c76a2b6ec
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundSomatostatin receptors (SSTR) and chemokine receptor CXCR4 are expressed in lymphomas, while the abundance is known to be heterogeneous in different subtypes of lymphomas. Targeting tumor cells expressing these receptors might add to therap
Externí odkaz:
https://doaj.org/article/4bcfaac8a4ac45098a111bf7611e93fa
Autor:
Mehrad Mahmoudian, Fatemeh Seyednasrollah, Liisa Koivu, Outi Hirvonen, Sirkku Jyrkkiö, Laura L. Elo
Publikováno v:
F1000Research, Vol 5 (2019)
Metastatic castration resistant prostate cancer (mCRPC) is one of the most common cancers with a poor prognosis. To improve prognostic models of mCRPC, the Dialogue for Reverse Engineering Assessments and Methods (DREAM) Consortium organized a crowds
Externí odkaz:
https://doaj.org/article/91388e2532dd4391bc24954296a2e9a7
Autor:
Sirpa Leppa, Judit M. Jørgensen, Marja-Liisa Karjalainen-Lindsberg, Klaus Beiske, Mette Pedersen, Kristina Drott, Annika Pasanen, Kristiina Karihtala, Susanna Mannisto, Leo Meriranta, Bente Wold, Marianne Brodtkorb, Unn Merete Fagerli, Thomas S. Larsen, Lars Munksgaard, Kaisa Sunela, Øystein Fluge, Sirkku Jyrkkio, Peter de Nully Brown, Harald Holte
Publikováno v:
Blood. 140:1768-1769
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1874a85a267c9a743ae74b5e0dfeebe
https://doi.org/10.1182/blood-2022-158183
https://doi.org/10.1182/blood-2022-158183
Publikováno v:
Blood. 140:9345-9346
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae2f9aaceb8afcfe0527d4e28fc82ba3
https://doi.org/10.1182/blood-2022-170380
https://doi.org/10.1182/blood-2022-170380
Autor:
Maare Arffman, Leo Meriranta, Harald Holte, Judit Jørgensen, Peter De Nully Brown, Sirkku Jyrkkio, Mats Jerkeman, Øystein Fluge, Magnus Björkholm, Matias Autio, Suvi-Katri Leivonen, Sirpa Leppa
Publikováno v:
Blood. 140:1316-1317
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f9730caa89ad17ccc287f25f8e29042
https://doi.org/10.1182/blood-2022-158426
https://doi.org/10.1182/blood-2022-158426